Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06831110 · ClinicalTrials.gov registry record
Aquagenic Wrinkling Prediction
A clinical trial of Carrier State and Aquagenic Wrinkling of Palms, sponsored by University of Iowa.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT06831110: Recruiting study of Carrier State and Aquagenic Wrinkling of Palms, sponsored by University of Iowa.
NCT06831110 is a study of Carrier State and Aquagenic Wrinkling of Palms that is actively recruiting participants, run by University of Iowa. The registered enrollment target is 2,000 participants, above the 537-participant average among 3 other Carrier State trials with a reported enrollment target (272% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06831110, a study of Carrier State and Aquagenic Wrinkling of Palms, is actively recruiting participants, sponsored by University of Iowa.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to determine whether an aquagenic wrinkling procedure (i.e., soaking hands in a water bath for up to 20 minutes) can be used as a screening tool for cystic fibrosis carrier status. Participants will complete one visit where they will undergo an aquagenic wrinkling procedure to see how their hands respond.
Primary Outcome
Photos of hands will be scored on a scale of 0 (no wrinkling) to 4 (severe wrinkling) at each minute by human observers.
Conditions Studied
Interventions
- PROCEDURE Aquagenic Wrinkling
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2025-03-06 |
| Est. Completion | 2026-12 |
What NCT06831110 shows while recruiting
NCT06831110 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 537-participant average among 3 other Carrier State trials with a reported enrollment target (272% higher).
The record links to 2 conditions, with Carrier State appearing as the primary indexed condition, and to 1 intervention - of which Aquagenic Wrinkling is the first listed.
NCT06831110 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT06831110 about?
NCT06831110 is a clinical study titled "Aquagenic Wrinkling Prediction". The goal of this observational study is to determine whether an aquagenic wrinkling procedure (i.e., soaking hands in a water bath for up to 20 minutes) can be used as a screening tool for cystic fibrosis carrier status. Participants will complete one visit where they will undergo an aquagenic wrin...
What is the current status of trial NCT06831110?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2025-03-06. Estimated completion is 2026-12.
What conditions does trial NCT06831110 study?
This clinical trial studies the following conditions: Carrier State, Aquagenic Wrinkling of Palms.
What interventions are being tested in trial NCT06831110?
The interventions under investigation include: Aquagenic Wrinkling (PROCEDURE).
Who is sponsoring clinical trial NCT06831110?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06831110 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carrier State
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI